Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 860

Document Document Title
WO/2006/053255A2
The present invention relates to novel synthetic derivatives of betulin and the use of such derivatives as pharmaceuticals. The present invention is directed to novel compounds of Formula (I) or a pharmaceutically acceptable salt or prod...  
WO/2006/050158A2
Personal care compositions and formulations, which include conventional concentrations of known hair and skin altering components and a cosmetically acceptable amount of oil-soluble betulin and allo-betulin esters or ethers derived from ...  
WO/2006/045171A3
The present invention refers to a process to obtain ergostane derivative dry steroids, such as physalins, including steps of: (a) grinding of dried parts of plant (s) from the Solanaceae species; (b) treatment of the said plant (s)' part...  
WO/2006/045171A2
The present invention refers to a process to obtain ergostane derivative dry steroids, such as physalins, including steps of: (a) grinding of dried parts of plant (s) from the Solanaceae species; (b) treatment of the said plant (s)' part...  
WO/2006/035525A1
A compound having a cyclolanostane framework, e.g., 9,19-cyclolanostan-3-ol or 24-methylene-9,19-cyclolanostan-3-ol, is used as an active ingredient for a medicine or a food/beverage for ameliorating hyperglycemia.  
WO/2006/032970A2
Processes are described for the conversion of a steroid substrate having a 4,7-carbonyl bridge to a structure comprising a 7&agr -alkoxycarbonyl substituent by reaction of the substrate with an alkoxy group source, preferably in the pres...  
WO/2006/031756A3
The present invention relates to a method of treating cancer selected from the group of cancers consisting of prostate cancer, renal cancer, breast cancer, ovarian cancer, CNS cancer, melanoma, lung cancer, and bladder cancer. This metho...  
WO/2006/002248A1
Betulin and dihydrobetulin acyl derivatives according to the present invention have been found to have potent anti-HIV activity. The compounds of the present invention have Formula I as described herein, or pharmaceutically acceptable sa...  
WO/2005/105824A1
A precess for preparation of timosaponin B II, which uses Chinese traditional drug Anemarrhena Rhizome or newly collected rhizoma or fibrous root of Anemarrhena Asphodeloides Bge. as raw material, and comprises isolation of tiBosaponin B...  
WO/2005/092912A1
The subject invention provides a compound according to Formula I, wherein Formula (1) is O, NOH, NO(1-4C)alkyl, NO(1-4C)acyl; Al-A5 are C, substituted with RI, or N, provided that at least one and not more than three of Al-A5 are N; or o...  
WO/2005/090380A1
Salts of 3-O-(3',3'-dimethylsuccinyl)Betulinic acid (DSB) are disclosed. Particularly, the preparation, pharmaceutical evaluation, and in vivo bioavailability evaluation of N-methyl-D-glucamine and alkali metal salt forms of DSB are disc...  
WO/2005/077968A3
The present invention relates to novel compounds which are 7alpha-substituted 17-alkylene-16 alpha-hydroxy steroidal estrogens (see formula I). This invention specifically relates to estrogen derivatives which contain 7 alpha -substituen...  
WO/2005/077968A2
The present invention relates to novel compounds which are 7alpha-substituted 17-alkylene-16 alpha-hydroxy steroidal estrogens (see formula I). This invention specifically relates to estrogen derivatives which contain 7 alpha -substituen...  
WO2005042422A3
An optical fiber, and a method of making such optical fiber, wherein the optical fiber exhibits a beatlength greater than about 0.5 meters, and the fiber is spun to provide a polarization mode dispersion in the spun state of said fiber w...  
WO/2005/044837A1
The conjugates of a hydrophilic polymer-Buxus's extracts or its derivatives were prepared by modifying Buxus's extracts such as cyclovirobuxine D and the like with said hydrophilic polymer such as polyglycol. With these conjugates, the p...  
WO/2005/042422A2
An optical fiber, and a method of making such optical fiber, wherein the optical fiber exhibits a beatlength greater than about 0.5 meters, and the fiber is spun to provide a polarization mode dispersion in the spun state of said fiber w...  
WO2004028455A3
Betulin and dihydrobetulin acyl derivatives according to the present invention have been found to have potent anti-HIV activity. The compounds of the present invention have Formula I as described herein, or pharmaceutically acceptable sa...  
WO/2005/030790A1
The present invention relates to novel synthetic derivatives of triterpenes and the use of such derivatives as pharmaceuticals. In some embodiments, the present invention is directed to the use of derivatives of triterpenes of the presen...  
WO2005007669A8
The present Invention relates to novel fusidic acid derivatives of general formula (I) wherein X represents halogen, trifluoromethyl, cyano, azido, alkyl, alkenyl or aryl, wherein. said alkyl, alkenyl or aryl are optionally substituted b...  
WO2005002496A3
The invention relates to a method of obtaining taxosteroids and the precursors thereof from hydrindane bicyclic systems. According to the invention, the compounds have a tetracyclic system which combines the structural characteristics of...  
WO/2005/007669A1
The present Invention relates to novel fusidic acid derivatives of general formula (I) wherein X represents halogen, trifluoromethyl, cyano, azido, alkyl, alkenyl or aryl, wherein. said alkyl, alkenyl or aryl are optionally substituted b...  
WO/2005/002496A2
The invention relates to a method of obtaining taxosteroids and the precursors thereof from hydrindane bicyclic systems. According to the invention, the compounds have a tetracyclic system which combines the structural characteristics of...  
WO/2005/000869A1
Novel pentacyclic steroids and pentacyclic D-homosteroids comprising: (i) the tetracyclic steroid ring system or tetracyclic D-homosteroid ring system, respectively; (ii) a C(3) substituent selected from the group consisting of (a) a hyd...  
WO2004075831A3
A novel method is provided to measure 11beta-hydroxysteroid dehydrogenase activity in intact whole animal tissues in the presence of systemically or ex vivo administered inhibitors of the enzyme. Inhibitors of the type 1 isoform (11beta ...  
WO/2004/075831A2
A novel method is provided to measure 11β-hydroxysteroid dehydrogenase activity in intact whole animal tissues in the presence of systemically or ex vivo administered inhibitors of the enzyme. Inhibitors of the type 1 isoform (11β -HSD...  
WO/2004/072092A1
The invention relates to novel derivatives of betulinic acid with increased activity for the treatment of carcinomas and HIV diseases, to a method for producing novel betulinic acid derivatives of this type and to their use as medicaments.  
WO/2004/055040A1
The present invention relates to a simple and new single pot process for the preparation of oryzanol from the oryzanol enriched saponifiable fraction of rice bran oil (RBO) soapstock.  
WO2003080778A3
This invention relates to methods for treating distillates obtained during the process of deodorizing various oils. More particularly, this invention relates to methods for recovering fatty acids, tocopherols, and sterols from a distilla...  
WO/2004/028455A2
Betulin and dihydrobetulin acyl derivatives according to the present invention have been found to have potent anti-HIV activity. The compounds of the present invention have Formula I as described herein, or pharmaceutically acceptable sa...  
WO2003092578A3
The present invention relates to improved methods for synthesising cyproterone acetate (17alpha-Acetoxy-6-chloro-1alpha, 2alpha-methylene-4,6-pregnadiene-3,20-dione) from solasodine. The methods of the invention are shorter as those of t...  
WO2003066659A3
The invention relates to an improved method for obtaining highly pure, crystalline betulinic acid from a methanolic extract of ground plane bark and/or plane rind. The invention also relates to a highly pure, crystalline betulinic acid, ...  
WO/2003/092578A2
The present invention relates to improved methods for synthesising cyproterone acetate (17&agr -Acetoxy-6-chloro-1&agr , 2&agr -methylene-4,6-pregnadiene-3,20-dione) from solasodine. The methods of the invention are shorter as those of t...  
WO/2003/080778A2
This invention relates to methods for treating distillates obtained during the process of deodorizing various oils. More particularly, this invention relates to methods for recovering fatty acids, tocopherols, and sterols from a distilla...  
WO/2003/066656A1
There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in that the crystalline complex is of space group P212121 having u...  
WO/2003/066032A1
There is provided a pharmaceutical aerosol formulation comprising (i) a compound of formula (I) or a solvate thereof as medicament, (ii) a liquified hydrofluoroalkane (HFA) gas as propellant; and characterised in that the compound of for...  
WO/2003/066026A1
There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein: (a) a glucocorticoid of formula (I), wherein R represents ethyl or a 5 membered heterocyclic aromati...  
WO/2003/066024A1
There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.  
WO/2003/066036A1
According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), or a solvate thereof, together with a long−acting β2−adrenoreceptor agon...  
WO/2003/066659A2
The invention relates to an improved method for obtaining highly pure, crystalline betulinic acid from a methanolic extract of ground plane bark and/or plane rind. The invention also relates to a highly pure, crystalline betulinic acid, ...  
WO/2003/062260A1
The invention provides novel compounds that are quaternary amine derivatives of betulin and other triterpenes. The compounds have antibacterial, antifungal, and surfactant properties.  
WO2002094849A3
Steroids containing a cyclohexene moiety are efficiently oxidized to the corresponding alpha, beta-unsaturated ketone using copper iodide and t-butyl hydroperoxide. A steroid compound containing the alpha, beta-unsaturated ketone structu...  
WO/2003/053993A1
The invention makes steroids available having formula (I) wherein R1 is O, (H,H), (H, OH), NOH, wherein OH is optionally etherified or esterified; R2 is hydrogen, or (C1-15)acyl; and the dotted lines indicate one or two optional bonds, f...  
WO2003020214A3
Disclosed are compounds that exhibit high transport across the intestinal wall of an animal. The compounds may optionally be linked to drugs that are poorly absorbed or poorly transported across the intestinal wall after oral administrat...  
WO/2003/020214A2
Disclosed are compounds that exhibit high transport across the intestinal wall of an animal. The compounds may optionally be linked to drugs that are poorly absorbed or poorly transported across the intestinal wall after oral administrat...  
WO2002017895A3
Aldosterone receptor antagonists for the prevention and treatment of cognitive dysfunction are disclosed.  
WO2001005805A9
The invention relates to novel C-19-halogen-substituted steroids of the androst-9(11)-ene series, i.e. 17 beta -hydroxy-19-halogen-androsta-4,9(11)-diene-3-one of general formula (I) and to methods for the production thereof. The inventi...  
WO2002049622A3
The invention relates to a matrix transdermal system containing (21S)-21-hydroxy-21-methyl-14,17-ethano-19-norpregna-4,9,15- triene-3,20-dione comprising a polyacrylate adhesive.  
WO/2002/094849A2
Steroids containing a cyclohexene moiety are efficiently oxidized to the corresponding &agr , β−unsaturated ketone using copper iodide and t−butyl hydroperoxide. A steroid compound containing the &agr , β−unsaturated ketone struc...  
WO/2002/092618A1
Disclosed is 17$g(a)-hydroxy-4-androstenh-3-one and the novel derivatives thereof of general formula (I), in addition to a method for the production thereof and medicaments containing said compounds are used to regulate spermatogenesis a...  
WO2002015920A3
We describe methods and compositions for treating a patient suffering from a hyperproliferative disorder or photoageing. Our methods involve blocking the activity of a retinol binding protein receptor (RBPr) in cells of the patient, and/...  

Matches 101 - 150 out of 860